Posts filed under: Summit for Clinical Operations Executives

ta-Scan SCOPE Europe 2018 Barcelona

Events Published on September 17, 2018

SCOPE Europe 2018: Join us at the First European Edition

Join us in October at the inaugural edition of SCOPE Europe in Barcelona, Spain. Visit the ta-Scan team at booth #6 or make an appointment with our attendees:

Chairperson’s Remarks

David Cocker, Chief Scientific Officer, ta-Scan Business Intelligence Systems, MDCPartners

DAY 1, Tuesday 16 October, 13:55h
David Cocker, Chief Scientific Officer, ta-Scan Business Intelligence Systems, MDCPartners / Anju Software
Track 1: Analytics-Driven Feasibility, Site Selection and Study Activation

 

About SCOPE Europe

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical operations executives, functional heads, category managers and those responsible for the planning and management of clinical trials in Europe and the rest of the world. The event will feature opening and closing plenary keynote sessions, three conference tracks, interactive breakout discussion groups and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials. Topics to be discussed include protocol development, global site selection, feasibility, site management, patient engagement, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, functional/full-service outsourcing and partnerships, new regulations and guideline, Risk-Based Monitoring (RBM), and improving overall quality and speed of clinical trials.

Register to join us

Have a look at the agendahttp://www.scopesummiteurope.com/2018-brochure-download-form

Register here to join us in Barcelona: https://chidb.com/reg/scoe/reg.asp

We hope to see you there!

Events Published on March 19, 2018

ta-Scan Client Testimonials at SCOPE 2018

During the SCOPE Summit in Orlando on February 12-15, 2018, we gathered some testimonials from ta-Scan clients. Learn how they leverage our clinical business intelligence platform to optimize their trial planning and feasibility.

SCOPE 2018 ta-Scan

Press Releases Published on February 12, 2018

MDCPartners announces 2018 innovation strategy this week at SCOPE Summit in Orlando (FL)

At the 9th annual SCOPE Summit, taking place in Orlando (Florida) this week, MDCPartners will present their two latest innovative designs to the public: ta-Scan Podium and InterSect. ta-Scan Podium is an online tablet application for Clinical Ops, Medical Affairs teams, and Medical Science Liaisons that enables users to find full profiles of all relevant Key Opinion Leaders and Key External Experts. InterSect is a desktop application that interfaces with the entire ta-Scan database on a semantic level. This unique query tool allows users to overlap internal data with the ta-Scan database and match and correlate the data in the system.

Both new innovative technologies are based on the organization’s well-known clinical business intelligence solution ta-Scan and its Semantic Search System. The patented Trial Cloud® and web mining software of ta-Scan, which is the largest semantically linked clinical database available on the web, combined with its powerful search capabilities, allow users to quickly find and analyze clinical data from multiple global public sources. The effortless delivery of in-depth and clear insights into any data point in the database is what classifies these tools as digital innovations.

This year’s SCOPE summit will focus on stimulating innovation, change, and personalized solutions to improve the clinical trial process. With hot topics such as clinical technology and innovation and artificial intelligence in clinical research, it’s important for exhibitors to stay on top of these latest developments. Where MDCPartners’ focus in the previous years was more on the introduction of new features and developments, this year it has shifted to more personalized solutions, with new modules being completely customizable to integrate private data.

“As a company which provides clinical intelligence, we believe it is crucial to gain greater insights into therapeutic area landscapes by using innovative and personalized solutions. That’s why we collaborate with our clients to answer the business questions they need. The goal of creating these new modules is not only to increase work efficiency, but also to make decision making more transparent and interoperable,” says CEO Mireille De Cré. MDCPartners will introduce the full product portfolio at the SCOPE summit and provide top pharma executives with private sessions to test and use the products live.

View GlobeNewswire press release: http://inpublic.globenewswire.com/releaseDetails.faces?rId=2168008

SCOPE 2018 ta-Scan David Cocker

Events Published on December 18, 2017

Catch up with ta-Scan during SCOPE 2018 at booth 300

On February 12-15, 2018 the ta-Scan team has its annual appointment with SCOPE 2018. Meet us in the Hyatt Regency in Orlando, Florida at booth 300 to discover what we have been working on the last year!

Find Medical Experts on the go with ta-Scan Podium

Next to a completely updated and optimized user interface, ta-Scan also has a new tool in store. Our mobile application ta-Scan Podium helps Clinical Ops, Medical Affairs teams, and Medical Science Liaisons to identify the right Medical Experts. Have a look at how Podium works.

ta-Scan Podium Mobile Semantic Search Expert Profiling

Meeting up

If you want to get an exclusive preview of Podium and learn more about our other (custom) software solutions, visit us on SCOPE 2018 at booth #300 or make an appointment with the ta-Scan team:

Summit for Clinical Operations Executives

The 9th Annual SCOPE Summit, taking place February 12-15, 2018 in Orlando, FL, will offer four stimulating days of in-depth discussions in 18 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions focused on advances and innovative solutions in all aspects of clinical trial planning, management and operations: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Resource Management and Capacity Planning, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence (AI), Post-Marketing Studies, Observational Research, Clinical Supply Chain, and Precision Medicine. View SCOPE’s programs here.

News Published on January 24, 2017

NEWS RELEASE: MDCPartners launches new ta-Scan software that ‘will revolutionize’ the way pharmaceutical companies plan for the future

Antwerp, Belgium | 24 January 2017 – MDCPartners today launches ta-Scan 5, an update of its global web-based platform that analyses clinical trial data. The new platform is set to revolutionize the way pharmaceutical researchers plan for the future, by providing unrivaled insights that will help inform future business decisions.

The new ta-Scan 5 is the first software of its kind to use exceptionally powerful algorithms to analyse clinical data from multiple global public sources in its patented Trial Cloud®. The new version 5 will mean that pharmaceutical companies are able to obtain more valuable insights on clinical research than ever before, via a more streamlined process.

The software will allow companies to go into more detail on clinical trial research than ever before, with access to over 250,000 clinical trials and 7 million scientific and clinical experts. This will provide unique insights on specific compounds, research institutes, clinical centers, patient populations, key investigators and competitor analysis to help strategic decision making.

“We believe the opportunity in clinical business intelligence is the freedom to look at data from multiple sources, from any region, combined into one system that’s easy to use. The new ta-Scan 5 does just that – it taps into vast amounts of information and provides comprehensive analysis that can be broken down easily. Pharmaceutical companies are now starting to realize their opportunities in gathering the most valuable business intelligence, and I believe the ability of this software will fundamentally change the way clinical research is planned and executed across the industry,” comments David Cocker, CSO for MDCPartners, who is presenting this week at the SCOPE Summit in Miami, Florida.

“For the first time ever, MDCPartners has been able to simplify complex trial-related queries and perform deep analysis using the most powerful algorithms yet. Using Real World Solutions, we can link internal and external information together through a portal, to generate a comprehensive landscape and get a full view of where the competing trials are conducted, and where the patient populations are. Before, we couldn’t link this information, now it is at our fingertips,” comments Dr Bart Naudts, Lead Data Architect at MDCPartners.

The ta-Scan web platform has been used by pharmaceutical and biotech researchers for the last decade. It has transformed and advanced the process of intelligence gathering and analyzes across the industry.

Media Enquiries

MDCPartners
Mireille De Cré
mireille.decre@mdcpartners.be
+32 (0) 3 870 97 50

Tonic Life Communications
Stan Jackson / Chrissie Hannah
stan.jackson@toniclc.com / chrissie.hannah@toniclc.com
+44 (0) 774 771 8279 / +44 (0)777 253 4646

***ENDS***

Notes to Editors

About ta-Scan

ta-Scan is an intelligence web platform for clinical development, which analyses data for trial planning, expert profiling, disease landscape and competitive intelligence, for researchers in the pharmaceutical and biotech industry. It was launched nearly a decade ago to transform and advance the intelligence gathering and analyses that enable clinical development.

Powerful algorithms enable researchers to bypass print publications, restrictive registries and dense databases for the insights they need to make evidence-based decisions. With ta-Scan, users can locate key opinion leader (KOL) associations, investigators with specific therapeutic experience, or institutes with the capacity to conduct complex protocols.

To find out more about ta-Scan, please visit: www.ta-scan.com/product

About ta-Scan 5

ta-Scan 5 is the updated model of ta-Scan, which was recently launched by MDCPartners at the SCOPE Summit in Miami, Florida, in January 2017. It offers a uniquely streamlined and simplified intelligence gathering process and improves data access and value, allowing for a more intuitive, business-oriented workflow.

ta-Scan 5 features a refined and robust search engine tool which activates alternative information pathways with the flexibility to adjust query filters with ease. The number and potential combination of trial-related queries is unrestricted, meaning that hundreds of data classes are semantically connected that can be accessed by one query.

To find out  more about ta-Scan 5, please visit: https://vimeo.com/mdcp/ta-scan5

About MDCPartners

Founded in 1999, MDCPartners specialises in business intelligence and strategic consultancy for the pharmaceutical and biotech industry. They combine drug development expertise with the latest data sciences to provide clinical trial optimisation, medical expert identification and competitive intelligence.

MDCPartners is a leader in the field of data mining and semantic processing. With their patented data solutions, their clients transform millions of dispersed data points into meaningful intelligences.

MDCPartners is headquartered in Antwerp, Belgium, with sales offices in the USA and Japan. It has three flagship products for global pharmaceutical data solutions, including:

  • ta-Scan: the flagship product ta-Scan is a web business intelligence platform that analyses clinical development programmes, trial and site data, and involvement of medical experts
  • normScan: the medical device standards monitoring tool, normScan, is tailored to the client’s medical device portfolio. normScan tracks all relevant device standards and regulatory documents that have been published or are in development
  • Real World Solutions: an evolving area of business for MDCPartners are the customised data solutions, which tap into a robust inventory of algorithms and unique visualisation tools. Users can gain optimal insights from data either as stand-alone or combined with public data

To find out more about MDCPartners, please visit: www.mdcpartners.be

MDCPartners ta-Scan 5 SCOPE 2017 Miami Florida

Events, News Published on October 28, 2016

Discover ta-Scan 5 at SCOPE 2017

Summit for Clinical Operations Executives

It’s never too early for good Year’s resolutions! Ours? Start off 2017 with a bang! Indeed, in January 2017, MDCPartners will travel to sunny Florida again for the yearly Summit for Clinical Operations Executives (SCOPE), and it goes without saying that we are already looking forward to it.

The 8th Annual SCOPE Summit, taking place January 24-26, 2017 in Miami, Florida in the Hyatt Regency, will offer three stimulating days of in-depth discussions in 13 different conferences, 6 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Lab Services, Precision Medicine and Biomarker-Driven Trials. View SCOPE’s programs here.

Introducing ta-Scan 5

ta-scan 5

Our business and IT teams will present the clinops experts at SCOPE ta-Scan‘s latest version we have been working on the last months: ta-Scan 5! This update includes a lot of new features and a complete style make-over to enhance the user experience. Join us in Miami to discover how our clinical business intelligence software and our public-private data integration skills can leverage today’s clinical big data challenges.

Meeting Up

ta-Scan team at SCOPE 2017 Miami Florida

If you want to get an exclusive preview of ta-Scan 5 and learn more about our software solutions, visit us at booth #702 or make an appointment with the team (from left to right, from top to bottom):

Bart Naudts, IT Partner
David Cocker, CSO
Mireille De Cré, CEO
Piet van Remortel, IT Partner
Matt Tumasz, Director of Business Development USA
Jonathan Crowther, Ph.D., Strategic Analyst Oncology
Alexandra Moens, Marketing Associate
Kristof Geentjens, Technical Product Manager

The ta-Scan clinical business intelligence team at SCOPE 2016

Events Published on March 7, 2016

ta-Scan’s Presentation at SCOPE 2016

Last month, 1,200 clinical operations executives gathered at SCOPE in Miami to hear the latest thinking on clinical operations optimization and emerging technologies.

MDCPartners’ ta-Scan team was there too and presented on the Global Site Selection, Feasibility Assessment and Site Management track. You can download David Cocker’s presentation on Advanced Feasibility Modelling here.

Missed SCOPE 2016? Meet MDCPartners at these events instead!
•   Oncology Leaders Forum (April 5-6 | Boston, Massachusetts)
•   Clinical Trial Innovation Summit (May 9-11 | Boston, Massachusetts)
•   Immunotherapy Forum Europe (September 21-22 | Berlin, Germany)
•   Big Data in Precision Medicine (November 1-2 | Washington, D.C.)

Events Published on January 20, 2016

Where can you find us in 2016?

First of all, a happy New Year and our best wishes to you all! 2016 has nearly been launched, but we already have some big events in store for this year. We’ll keep sharing innovative knowledge with our healthcare business network at expert meetings. Below you can find a chronological list of conferences we will be attending this year. You can also find us exhibiting our clinical business intelligence software ta-Scan there. We hope to meet you there!

SCOPE Summit

February 23-25 | Miami, Florida

SCOPE 2016 Summit for Clinical Operations Executives

The 7th Annual SCOPE Summit for clinical operations executives will offer three stimulating days of in-depth discussions in twelve different conferences, four pre-conference workshops and two symposia focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Statistics and Biomarker-Driven Trials. Click here to view the meeting program.

Learn more about Advanced Feasibility Modelling from David Cocker’s presentation, and meet the ta-Scan team personally at booth 506 & 508!

Oncology Leaders Forum

April 5-6 | Boston, Massachusetts

Oncology Leaders Forum 2016 Phacilitate

Join the most senior oncology event in the pharmaceutical sector where 88% of the audience are Director-level and above for two days of strategic thinking and networking. Recognized as the leader by the leaders, the Oncology Leaders Forum is the event of choice for senior translational and clinical oncology R&D executives driving the development, registration and launch of novel cancer therapeutics of all classes, plus companion diagnostics. Click here to view the draft meeting agenda.

Hear David Cocker’s introductory keynote:

“The evolution towards precision: a chronology of transition”
Standards of care. What’s changing in therapy focus?
•  Scenario-based enrollment: forecasting and validation
•  Footprint of global trial activity. Who is generating the data? KOL ranking
•  Where will I be conducting my next trial?
•  The death of the longitudinal drug development paradigm

Clinical Trial Innovation Summit

May 9-11 | Boston, Massachusetts

Clinical Trial Innovation Summit 2016 Banner
Cambridge Healthtech Institute’s Fifth Annual Clinical Trial Innovation Summit will bring together leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. The 2016 program focuses on key issues and opportunities in the clinical trial industry, including Patient Recruitment, Site Selection, Data Integration, Existing Data Sources, Mobile Tech, Project Management, Outsourcing, Vendor Management, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring and Clinical Auditing. Click here to view the final meeting brochure.

Immunotherapy Forum Europe

September 21-22 | Berlin, Germany

Phacilitate Leaders Europe Immunotherapy Europe Berlin 2016

Immuno-oncology is the hot topic across the life science sector following a range of recent successes and approvals. Be part of this new event and meet leaders from across the sector to discover the path to commercialization in Europe. Click here to view the meeting agenda.

Big Data in Precision Medicine

November 1-2 | Washington, D.C.

MDCPartners Big Data in Precision Medicine Conference

Meet all the key stakeholders under one roof: Pharma, Biotech, CROs, Health Systems, CMOs and Government. Key themes will include: integrating big data across drug development, big data in translational science and clinical trialsprecision medicine analytics ecosystem, big data enabling the future of healthcare. Click here to view the meeting agenda.

More info coming soon!

Do you want to stay updated on upcoming ta-Scan events and product and industry news? Keep an eye on our website, or follow us on LinkedIn or Twitter and never miss out.

Events Published on December 21, 2015

Join the ta-Scan Team at SCOPE 2016!

February 23-25, 2016 | Miami

SCOPE 2016 Summit for Clinical Operations Executives

The year hasn’t ended yet, but we are already looking forward to new events in 2016: in February, the ta-Scan team will be present in Miami at SCOPE 2016, the annual Summit for Clinical Operations Executives. Click here to view the meeting program.

Learn more about advanced feasibility modelling from CSO David Cocker’s presentation:

“Advanced Feasibility Modelling”
Tuesday, February 23, 3:20 – 3:35 PM
Track: Global Site Selection, Feasibility Assessment and Site Management

Presentation abstract: From unrealistic protocols to delinquent sites, feasibility catches the rap as the leading contributing factor for missed timelines and budget overruns. Feasibility basically is a confidence prediction of your downstream research network. But what if internal data is inadequate to provide a reliable assessment? Patient recruitment simulation software is plugging many information gaps in the feasibility departments. This presentation highlights new data sources, algorithms and visualizations to shore up your feasibility assessments.

Speaker bio: David Cocker is an experienced healthcare executive with a deep understanding of global clinical operations. Graduated as a biomedical engineer, he has been in the central clinical laboratory business for 25 years founding some of Europe’s largest clinical labs. As MDCPartners’ CSO, David now works with data scientists and project managers to develop information technologies to help pharmaceutical companies discover valuable insights from public data.

You can also meet us personally at booths # 506 & 508 to see a live demonstration of our ta-Scan software. Just drop by or make an appointment with Matt Tumasz or David Cocker.

If ta-Scan is new for you, you can learn about its concepts in this short, informative ta-Scan video.

Browse categories


Browse tags